Cemia in young children,' The American Journal of Epidemiology, vol. 177, no. 11, pp. 1255262,

Cemia in young children,” The American Journal of Epidemiology, vol. 177, no. 11, pp. 1255262, 2013. A. Shankar, J. Xiao, along with a. Ducatman, “Perfluorooctanoic acid and cardiovascular NPY Y5 receptor Agonist medchemexpress disease in US adults,” Archives of Internal Medicine, vol. 172, no. 18, pp. 1397403, 2012. A. Shankar, J. Xiao, plus a. Ducatman, “Perfluoroalkyl chemicals and chronic kidney disease in US Adults,” The American Journal of Epidemiology, vol. 174, no. 8, pp. 89300, 2011. D. Melzer, N. Rice, M. H. Depledge, W. E. Henley, and T. S. Galloway, “Association amongst serum perfluorooctanoic acid (PFOA) and thyroid illness inside the U.S. National Wellness and Nutrition Examination Survey,” Environmental Health Perspectives, vol. 118, no. 5, pp. 68692, 2010. V. Gallo, G. Leonardi, B. Genser et al., “Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a p38 MAPK Agonist MedChemExpress population with elevated PFOA exposure,” Environmental Health Perspectives, vol. 120, no. five, pp. 65560, 2012. N. Kudo and Y. Kawashima, “Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals,” Journal of Toxicological Sciences, vol. 28, no. two, pp. 497, 2003. L. Cui, Q.-F. Zhou, C.-Y. Liao, J.-J. Fu, and G.-B. Jiang, “Studies on the toxicological effects of PFOA and PFOS on rats employing histological observation and chemical evaluation,” Archives of Environmental Contamination and Toxicology, vol. 56, no. 2, pp. 33849, 2009. L. M. Eldasher, X. Wen, M. S. Tiny, K. M. Bircsak, L. L. Yacovino, and L. M. Aleksunes, “Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid,” Toxicology, vol. 306, no. four, pp. 10813, 2013. A. G. Abdellatif, V. Preat, H. S. Taper, and M. Roberfroid, “The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator,” Toxicology and Applied Pharmacology, vol. 111, no. three, pp. 53037, 1991. V. Bindhumol, K. C. Chitra, and P. P. Mathur, “Bisphenol A induces reactive oxygen species generation within the liver of male rats,” Toxicology, vol. 188, no. 2-3, pp. 11724, 2003. D. Bagchi, J. Balmoori, M. Bagchi, X. Ye, C. B. Williams, and S. J. Stohs, “Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative tension and tissue harm in the liver and brain tissues of mice,” Toxicology, vol. 175, no. 1, pp. 732, 2002. A. P. Senft, T. P. Dalton, D. W. Nebert, M. B. Genter, R. J. Hutchinson, and H. G. Shertzer, “Dioxin increases reactive[12]Conflict of InterestsThe authors declare that there isn’t any conflict of interests.[13]AcknowledgmentsThis study was supported by the National Organic Science Foundation of China (no. 81060056) and Jiangxi Provincial Education Development (no. GJJ12083).[14][15]
NIH Public AccessAuthor ManuscriptBiochim Biophys Acta. Author manuscript; readily available in PMC 2015 January 01.Published in final edited form as: Biochim Biophys Acta. 2014 January ; 1843(1): . doi:ten.1016/j.bbamcr.2013.06.027.NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptRegulation of Proteolysis by Human Deubiquitinating EnzymesZiad M. Eletr and Keith D. Wilkinson Department of Biochemistry, Emory University, Atlanta GAAbstractThe post-translational attachment of a single or various ubiquitin molecules to a protein generates a range of targeting signals that are applied in numerous distinctive ways in the cell. Ubiquitination can alter the activity, localization, protein-protein interactions or stability of the targeted protein. Further, an extremely significant number.